Generation of Heavy and Light Chains (Chimeric Antibodies)
Part of the
Springer Protocols Handbooks
book series (SPH)
Antibodies are highly specific, naturally evolved molecules that recognize and eliminate pathogens and tumour associated antigens. The organisation into distinct structural and functional domains facilitates their engineering. Driven by a variety of antibody engineering methods and technological developments, chimeric and humanized antibodies are commonly used as therapeutics for cancer, infectious and inflammatory diseases, for imaging or in targeted delivery systems. This chapter describes the cloning and expression of chimeric antibodies using Lonza’s “double-gene vectors” (Lonza Biologics’ Glutamine Synthetase (GS) gene expression system) in mammalian cells.
KeywordsGlutamine Synthetase Chimeric Antibody Light Chain Gene Light Chain Variable Region Constant Region Gene
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Aarden L, Ruuls SR et al (2008) Immunogenicity of anti-tumor necrosis factor antibodies-toward improved methods of anti-antibody measurement. Curr Opin Immunol 20(4):431–435PubMedCrossRefGoogle Scholar
Bebbington CR, Renner G et al (1992) High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology (N Y) 10(2):169–175CrossRefGoogle Scholar
Jones PT, Dear PH et al (1986) Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321(6069):522–525PubMedCrossRefGoogle Scholar
Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256(5517):495–497PubMedCrossRefGoogle Scholar
Morrison SL, Johnson MJ et al (1984) Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci USA 81(21):6851–6855PubMedCrossRefGoogle Scholar
Shawler DL, Bartholomew RM et al (1985) Human immune response to multiple injections of murine monoclonal IgG. J Immunol 135(2):1530–1535PubMedGoogle Scholar